Physician profile
Keith Aziz
NPI 1285012351
$10,878.65
in general payments reported to CMS, 2019-2025
14 companies · $923 in 2025
The $923 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $785 · 2020: $121 · 2021: $2,610 · 2022: $6,021 · 2023: $289 · 2024: $130 · 2025: $923.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $842 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $841.74 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,956.36 | 2022 | |
| Legacy Ortho LLC | $2,412.16 | 2021 | |
| Axogen | $1,983.16 | 2022-2025 | |
| Team 1, LLC | $1,573.48 | 2022-2025 | |
| Acumed LLC | $665.46 | 2019 | |
| Synthes Gmbh | $611.89 | 2025 | |
| Skeletal Dynamics INC | $141.66 | 2021 | |
| Trimed, INC. | $121.49 | 2020 | |
| Pacira Therapeutics, INC. | $119.31 | 2019 | |
| Integra Lifesciences Corporation | $108.09 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Alnylam Pharmaceuticals INC. | $67.50 | 2024 | Onpattro |
| Anika Therapeutics, INC. | $62.27 | 2024 | Integrity, Wristmotion |
| Smith+Nephew, INC. | $38.86 | 2021 | |
| Endo Pharmaceuticals INC. | $16.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Aziz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.